Search - tctmd.com

Displaying 221 - 240 of 872

Sort: Relevancy | Date

Presentation TCT 2015

Transcatheter Tricuspid Regurgitation Treatment 2: Mitralign

Presenter: Rebecca T. Hahn, Joachim Schofer

October 15, 2015

Presentation TCT 2015

Transcatheter Tricuspid Regurgitation Treatment 1: MitraClip

Presenter: Rebecca T. Hahn, Joachim Schofer, Brij Maini

October 15, 2015

Presentation TCT 2015

Paravalvular Regurgitation After TAVR 2: Importance of Valve Sizing and Calcium Patterns to Predict and Prevent Paravalvular Regurgitation After TAVR

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Jeffrey J. Popma

October 15, 2015

Presentation TCT 2015

Paravalvular Regurgitation After TAVR 1: KEYNOTE LECTURE Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Susheel Kodali

October 15, 2015

Presentation TCT 2015

Transcatheter Valve Implantation in the IVC/SVC for Tricuspid Regurgitation

Presenter: Rebecca T. Hahn, Joachim Schofer, Hans R. Figulla

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 3: Controversy 2 Importance and Methods of Neurocognitive Functional Assessments

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Ronald M. Lazar

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 2: Controversy 1 Need for Cerebral Protection (Universal vs Selective)

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem

October 15, 2015

Presentation TCT 2015

Surgical Approaches and Outcomes to Tricuspid Regurgitation

Presenter: Rebecca T. Hahn, Joachim Schofer, James S. Gammie

October 15, 2015

Presentation TCT 2015

Intervention for Tricuspid Regurgitation: What Do the Guidelines Say? (ACC/AHA and ESC/EACTS)

Presenter: Rebecca T. Hahn, Joachim Schofer, Alec S. Vahanian

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 1: Reassessing Incidence (Declining), Etiologic Factors, and Remaining Controversies

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem

October 15, 2015

Presentation TCT 2015

Assessing Postdevice Paravalvular Aortic Regurgitation

Presenter: Jeroen J. Bax, Paul A. Grayburn, Rebecca T. Hahn

October 15, 2015

Presentation TCT 2015

TCT 111: Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement Insights From the US TVT National Registry

Presenter: Steven R. Bailey, Patrick W. Serruys, Kreton Mavromatis

October 15, 2015

Presentation TCT 2015

Miscellaneous Emerging Technologies 3: Dynamic Transcatheter Mitral Valve Repair for Patients With End-Stage Functional Mitral Valve Regurgitation

Presenter: Greg L. Kaluza, Joachim Schofer, Miriam Silaschi

October 15, 2015

Presentation TCT 2015

The Tricuspid Valve Occluder: A Novel Device for Tricuspid Regurgitation

Presenter: Greg L. Kaluza, Joachim Schofer, Mohammad Qasim Raza

October 15, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Industry News

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

October 15, 2015

Presentation TCT 2015

Implications of Tricuspid Regurgitation and/or Severe Pulmonary Hypertension in Patients Undergoing MV Surgery or MitraClip

Presenter: Stephan Baldus, Saibal Kar, Jason H. Rogers

October 14, 2015

Presentation TCT 2015

Case Introduction: A Complex Diabetic Patient With Heart Failure, Ischemia, and Mitral Regurgitation

Presenter: John D. Puskas

October 14, 2015

Presentation TCT 2015

Arterys: MRI-based Assessment and Quantification of Mitral and Tricuspid Regurgitation

Presenter: Andrew Farb, Jason H. Rogers, Albert Hsiao

October 14, 2015

Advertisement

Transcatheter Tricuspid Regurgitation Treatment 2: Mitralign

Transcatheter Tricuspid Regurgitation Treatment 1: MitraClip

Paravalvular Regurgitation After TAVR 2: Importance of Valve Sizing and Calcium Patterns to Predict and Prevent Paravalvular Regurgitation After TAVR

Paravalvular Regurgitation After TAVR 1: KEYNOTE LECTURE Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Transcatheter Valve Implantation in the IVC/SVC for Tricuspid Regurgitation

Stroke After TAVR 3: Controversy 2 Importance and Methods of Neurocognitive Functional Assessments

Stroke After TAVR 2: Controversy 1 Need for Cerebral Protection (Universal vs Selective)

Surgical Approaches and Outcomes to Tricuspid Regurgitation

Intervention for Tricuspid Regurgitation: What Do the Guidelines Say? (ACC/AHA and ESC/EACTS)

Stroke After TAVR 1: Reassessing Incidence (Declining), Etiologic Factors, and Remaining Controversies

Assessing Postdevice Paravalvular Aortic Regurgitation

TCT 111: Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement Insights From the US TVT National Registry

Miscellaneous Emerging Technologies 3: Dynamic Transcatheter Mitral Valve Repair for Patients With End-Stage Functional Mitral Valve Regurgitation

The Tricuspid Valve Occluder: A Novel Device for Tricuspid Regurgitation

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

Implications of Tricuspid Regurgitation and/or Severe Pulmonary Hypertension in Patients Undergoing MV Surgery or MitraClip

Case Introduction: A Complex Diabetic Patient With Heart Failure, Ischemia, and Mitral Regurgitation

Arterys: MRI-based Assessment and Quantification of Mitral and Tricuspid Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content